Results 1 to 10 of about 86,560 (256)

Nanomedicine Approaches for Corneal Diseases [PDF]

Journal of Functional Biomaterials, 2015
Corneal diseases are the third leading cause of blindness globally. Topical nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antibiotics and tissue transplantation are currently used to treat corneal pathological conditions. However, barrier properties of the ocular surface necessitate high concentration of the drugs applied in the eye ...
Lakshminarayanan R, Shyam Chaurasia, Rajiv Mohan   +2 more
exaly   +4 more sources

Artificial intelligence and corneal diseases. [PDF]

Curr Opin Ophthalmol, 2022
Purpose of review Artificial intelligence has advanced rapidly in recent years and has provided powerful tools to aid with the diagnosis, management, and treatment of ophthalmic diseases. This article aims to review the most current clinical artificial intelligence applications in anterior segment diseases, with an emphasis on ...
Kang L, Ballouz D, Woodward MA.
europepmc   +3 more sources

Methylation in cornea and corneal diseases: a systematic review [PDF]

Cell Death Discovery
Corneal diseases are among the primary causes of blindness and vision loss worldwide. However, the pathogenesis of corneal diseases remains elusive, and diagnostic and therapeutic tools are limited.
Yutong Xia, Kuangqi Chen, Qianjie Yang, Zhitong Chen, Le Jin, Liyue Zhang, Xin Yu, Liyin Wang, Chen Xie, Yuan Zhao, Ye Shen, Jianping Tong   +11 more
doaj   +2 more sources

Cell Therapy of Corneal Diseases. [PDF]

Cornea, 2016
Mesenchymal stem cells isolated from connective tissues are pluripotent and differentiate into phenotypes of connective tissue cell lineages (osteoblasts, chondrocytes, and adipocytes) in vitro and in vivo. They have been used to treat mouse models of connective tissue disease such as lumican-null (Lum) and mucopolysaccharidosis (Gusb) mice ...
Kao WW, Coulson-Thomas VJ.
europepmc   +4 more sources

Mesenchymal Stem Cells and Exosomes: A Novel Therapeutic Approach for Corneal Diseases [PDF]

International Journal of Molecular Sciences, 2023
Hun Lee, Jae Yong Kim, Ho Seok Chung
exaly   +2 more sources

Metabolomics in Corneal Diseases: A Narrative Review from Clinical Aspects [PDF]

Metabolites, 2023
Yu Chi Liu, Alvin Teo, Liu Yu-Chi
exaly   +2 more sources

The Role of Rho Kinase Inhibitors in Corneal Diseases [PDF]

Drug Design, Development and Therapy
Georgios D Panos, Stefan Futterknecht, Zísis Gatzioufas   +2 more
exaly   +2 more sources

Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases [PDF]

Pharmaceutics, 2020
Prabhakar Bastola, , Liujiang Song
exaly   +2 more sources

Corneal Disease & Transplantation

Journal of Clinical Medicine, 2022
Corneal diseases represent the third leading cause of blindness worldwide, and corneal transplantation, which aims at restoring corneal clarity and vision, is the most frequently performed transplant worldwide [...]
Giulia Coco, Vito Romano
openaire   +5 more sources

Early Visibility of Cellular Aggregates and Changes in Central Corneal Thickness as Predictors of Successful Corneal Endothelial Cell Injection Therapy

Cells, 2023
(1) Background: Cell injection therapy is an emerging treatment for bullous keratopathy (BK). Anterior segment optical coherence tomography (AS-OCT) imaging allows the high-resolution assessment of the anterior chamber. Our study aimed to investigate the
Evan N. Wong, Valencia H. X. Foo, Gary S. L. Peh, Hla M. Htoon, Heng-Pei Ang, Belinda Y. L. Tan, Hon-Shing Ong, Jodhbir S. Mehta   +7 more
doaj   +1 more source